REGENERON PHARMACEUTICALS, INC. Additional Paid-in Capital 2009-2026 | REGN
Beta
What is REGENERON PHARMACEUTICALS, INC.'s current additional paid-in capital?
REGENERON PHARMACEUTICALS, INC. (REGN) annual additional paid-in capital for 2025 was $13.99B, a 8.86% increase from 2024. REGENERON PHARMACEUTICALS, INC. additional paid-in capital for the quarter ending March 31, 2026 was $14.40B.
What was REGENERON PHARMACEUTICALS, INC.'s additional paid-in capital in 2024?
REGENERON PHARMACEUTICALS, INC. annual additional paid-in capital for 2024 was $12.86B, a 13.23% increase from 2023.
What was REGENERON PHARMACEUTICALS, INC.'s additional paid-in capital in 2023?
REGENERON PHARMACEUTICALS, INC. annual additional paid-in capital for 2023 was $11.35B, a 14.12% increase from 2022.
What is REGENERON PHARMACEUTICALS, INC.'s 5-year additional paid-in capital CAGR?
REGENERON PHARMACEUTICALS, INC. additional paid-in capital grew at a compound annual growth rate (CAGR) of 15.82% from FY2020 to FY2025, going from $6.72B to $13.99B over 5 years.
Additional Paid-in Capital History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+15.8%
FY2020
$6.72B
→
FY2025
$13.99B
0910111213141516171819202122232425
5 years selected
Additional Paid-in Capital History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $13.99B | +8.9% | 10-K |
| FY2024 | $12.86B | +13.2% | 10-K |
| FY2023 | $11.35B | +14.1% | 10-K |
| FY2022 | $9.95B | +23.0% | 10-K |
| FY2021 | $8.09B | +20.4% | 10-K |
| FY2020 | $6.72B | +51.7% | 10-K |
| FY2019 | $4.43B | +13.2% | 10-K |
| FY2018 | $3.91B | +11.3% | 10-K |
| FY2017 | $3.51B | +15.9% | 10-K |
| FY2016 | $3.03B | -2.2% | 10-K |
| FY2015 | $3.10B | +26.5% | 10-K |
| FY2014 | $2.45B | +19.8% | 10-K |
| FY2013 | $2.05B | +16.0% | 10-K |
| FY2012 | $1.76B | +0.5% | 10-K |
| FY2011 | $1.75B | +11.4% | 10-K |
| FY2010 | $1.58B | +17.9% | 10-K |
| FY2009 | $1.34B | - | 10-K |
Company: REGENERON PHARMACEUTICALS, INC.Ticker: REGNSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →